Effects of combination antihypertensive therapy on intracardiac hemodynamics and blood vessels in patients with coronary heart disease, post-infarction cardiosclerosis and arterial hypertension
DOI:
https://doi.org/10.14739/2310-1210.2023.4.284248Keywords:
fixed-dose combination, ACE inhibitor, amlodipine, angiotensin 2 receptor blocker, coronary heart disease, post-infarction cardiosclerosis, blood pressure, left ventricular diastolic functionAbstract
The aim of the work is to assess the effectiveness of prescribing a fixed-dose combination of amlodipine with the ACE inhibitor lisinopril or with the angiotensin 2 receptor blocker valsartan in patients with coronary artery disease, acute coronary syndrome with hypertensive disease regarding the impact on the structural and functional parameters of the heart and extracranial branches of the brachiocephalic arteries.
Materials and methods. General clinical examination of 108 patients with postinfarction cardiosclerosis and hypertension was done within 12 months. The patients were allocated to two groups. Patients in the first group (n = 50) were assigned a fixed-dose combination of lisinopril and amlodipine (20 mg and 5 mg, respectively), and patients in the second group (n = 58) received a fixed-dose combination of valsartan with amlodipine (160 mg and 5 mg, respectively). The patients were monitored for 12 months, including general clinical examinations, measurements of office blood pressure (BP), 24-hour BP monitoring, echo-dopplerographic examination of the heart and brachiocephalic arteries, determination of the composite endpoint. Statistical analysis of the obtained data was performed using Microsoft Excel, IBM SPSS Statistics v.23.
Results. A significant difference in echocardiographic data has been proved (p < 0.05) regarding left ventricle (LV) dimensions in both study groups. A significant decrease in the E/A ratio and an insignificant decrease in E/E’ (p > 0.05) have been found in the first group. When analyzing the indicators of diastolic function in the second group, a highly significant (p < 0.05) decrease in E/A, E/E’, IO of the LA has been revealed; data analysis on the morphofunctional state indicators of the extracranial arteries has shown a CIM reduction and a decrease in PSV and RI.
Conclusions. Prescriptions of the fixed-dose combination of amlodipine with the ACE inhibitor lisinopril was more effective in terms of the LV measurements (p < 0.05) and LV diastolic function as evidenced by decreased E/A, E/E’ and IO of the LA (p < 0.05) as compared to the data in the group of amlodipine with the angiotensin 2 receptor blocker valsartan. Both fixed-dose combinations were effective in reducing the CIM thickness, decreasing PSV and RI when analyzing the morphofunctional state findings of the extracranial arteries.
References
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., Kahan, T., Mahfoud, F., Redon, J., Ruilope, L., Zanchetti, A., Kerins, M., Kjeldsen, S. E., Kreutz, R., Laurent, S., Lip, G. Y. H., … ESC Scientific Document Group (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European heart journal, 39(33), 3021-3104. https://doi.org/10.1093/eurheartj/ehy339
SCORE2-OP working group and ESC Cardiovascular risk collaboration (2021). SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. European heart journal, 42(25), 2455-2467. https://doi.org/10.1093/eurheartj/ehab312
Ferreira, J. P., Girerd, N., Bozec, E., Machu, J. L., Boivin, J. M., London, G. M., Zannad, F., & Rossignol, P. (2016). Intima-Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population-Based Cohort (STANISLAS Cohort Study). Journal of the American Heart Association, 5(6), e003529. https://doi.org/10.1161/JAHA.116.003529
Takamura, K., Fujimoto, S., Mita, T., Kawaguchi, Y. O., Kurita, M., Kadowaki, S., Kamo, Y., Aoshima, C., Nozaki, Y. O., Takahashi, D., Kudo, A., Hiki, M., Tomizawa, N., Ikeda, F., Satoh, H., Watada, H., & Minamino, T. (2022). Identification of Risk Factors for Coronary Artery Disease in Asymptomatic Patients with Type 2 Diabetes Mellitus. Journal of clinical medicine, 11(5), 1226. https://doi.org/10.3390/jcm11051226
Peters, S., Trümmel, M., Meyners, W., Koehler, B., & Westermann, K. (2005). Valsartan versus ACE inhibition after bare metal stent implantation--results of the VALVACE trial. International journal of cardiology, 98(2), 331-335. https://doi.org/10.1016/j.ijcard.2004.05.062
Kotseva, K., De Backer, G., De Bacquer, D., Rydén, L., Hoes, A., Grobbee, D., Maggioni, A., Marques-Vidal, P., Jennings, C., Abreu, A., Aguiar, C., Badariene, J., Bruthans, J., Castro Conde, A., Cifkova, R., Crowley, J., Davletov, K., Deckers, J., De Smedt, D., De Sutter, J., … EUROASPIRE Investigators* (2019). Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. European journal of preventive cardiology, 26(8), 824-835. https://doi.org/10.1177/2047487318825350
De Bacquer, D., Ueda, P., Reiner, Ž., De Sutter, J., De Smedt, D., Lovic, D., … for the EUROASPIRE IV and V National Coordinators. (2022). Prediction of recurrent event in patients with coronary heart disease : the EUROASPIRE Risk Model : results from a prospective study in 27 countries in the WHO European region-The EURObservational Research Programme (EORP) of the European Society of Cardiology (ESC). European journal of preventive cardiology, 29(2), 328-339. https://doi.org/10.1093/eurjpc/zwaa128
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., Isasi, C. R., Jiménez, M. C., Jordan, L. C., Judd, S. E., Lackland, D., Lichtman, J. H., Lisabeth, L., Liu, S., Longenecker, C. T., Mackey, R. H., … American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2017). Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation, 135(10), e146-e603. https://doi.org/10.1161/CIR.0000000000000485
Rea, F., Corrao, G., Merlino, L., & Mancia, G. (2018). Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension. European heart journal, 39(40), 3654-3661. https://doi.org/10.1093/eurheartj/ehy420
Salam, A., Kanukula, R., Atkins, E., Wang, X., Islam, S., Kishore, S. P., Jaffe, M. G., Patel, A., & Rodgers, A. (2019). Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials. Journal of hypertension, 37(9), 1768-1774. https://doi.org/10.1097/HJH.0000000000002096
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., Agewall, S., Dickstein, K., Edvardsen, T., Escaned, J., Gersh, B. J., Svitil, P., Gilard, M., Hasdai, D., Hatala, R., Mahfoud, F., … ESC Scientific Document Group (2020). 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European heart journal, 41(3), 407-477. https://doi.org/10.1093/eurheartj/ehz425
Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., Lancellotti, P., Muraru, D., Picard, M. H., Rietzschel, E. R., Rudski, L., Spencer, K. T., Tsang, W., & Voigt, J. U. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European heart journal. Cardiovascular Imaging, 16(3), 233-270. https://doi.org/10.1093/ehjci/jev014
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., 3rd, Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., Marino, P., Oh, J. K., Popescu, B. A., & Waggoner, A. D. (2016). Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 29(4), 277-314. https://doi.org/10.1016/j.echo.2016.01.011
Aboyans, V., Ricco, J. B., Bartelink, M. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J. P., Czerny, M., De Carlo, M., Debus, S., Espinola-Klein, C., Kahan, T., Kownator, S., Mazzolai, L., Naylor, A. R., Roffi, M., Röther, J., Sprynger, M., Tendera, M., Tepe, G., … ESC Scientific Document Group (2018). 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European heart journal, 39(9), 763-816. https://doi.org/10.1093/eurheartj/ehx095
Sprynger, M., Rigo, F., Moonen, M., Aboyans, V., Edvardsen, T., de Alcantara, M. L., Brodmann, M., Naka, K. K., Kownator, S., Simova, I., Vlachopoulos, C., Wautrecht, J. C., Lancellotti, P., & EACVI Scientific Documents Committee (2018). Focus on echovascular imaging assessment of arterial disease: complement to the ESC guidelines (PARTIM 1) in collaboration with the Working Group on Aorta and Peripheral Vascular Diseases. European heart journal. Cardiovascular Imaging, 19(11), 1195-1221. https://doi.org/10.1093/ehjci/jey103
North American Symptomatic Carotid Endarterectomy Trial Collaborators, Barnett, H. J. M., Taylor, D. W., Haynes, R. B., Sackett, D. L., Peerless, S. J., Ferguson, G. G., Fox, A. J., Rankin, R. N., Hachinski, V. C., Wiebers, D. O., & Eliasziw, M. (1991). Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. The New England journal of medicine, 325(7), 445-453. https://doi.org/10.1056/NEJM199108153250701
Sayin, B. Y., & Oto, A. (2022). Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options. Cardiology and therapy, 11(2), 203-230. https://doi.org/10.1007/s40119-022-00260-y
Malnick, S. D., & Somin, M. (2007). The VALIDD study. Lancet, 370(9591), 931-932. https://doi.org/10.1016/S0140-6736(07)61434-2
Gupta, A., Mackay, J., Whitehouse, A., Godec, T., Collier, T., Pocock, S., Poulter, N., & Sever, P. (2018). Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial. Lancet, 392(10153), 1127-1137. https://doi.org/10.1016/S0140-6736(18)31776-8
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
